Sharon Gazit


Head Corporate and Technology Department

Adv. Gazit is Head of the Corporate and Technology Department of the firm, and a member of the Executive Committee.

Adv. Gazit specializes in international-commercial transactions with a dominant technology component, and advises hi-tech and technology companies on their continuous operations and on merger and acquisition transactions in which they are involved in. In addition, Adv. Gazit specializes in corporate financing, commercial agreements, technology agreements, and commercial and technology issues relating to intellectual property.

Adv. Gazit has been recognized as a leading partner in the Israeli private equity and hi-tech field since its early days, and frequently advises companies, both in the traditional industry field and in the hi-tech and life sciences field, from their establishment and through their operations as mature and active companies. In addition, Adv. Gazit advises venture capital funds, companies and investors on investment transactions and the realization of holdings. Adv. Gazit’s many years of experience provides her with a unique outlook, a deep understanding of the client’s business requirements, and an ability to settle both non-complex and complex transactions.

Adv. Gazit possess significant expertise relating to transactions involving intellectual property licensing, especially in the life sciences fields, and has represented companies in this field for many years, including pharmaceutical companies, medical instruments companies, technology incubators and research centers. Adv. Gazit possesses widespread working relations with the relevant regulatory entities in the field, and advises clients on various matters, including commercial agreements through the research and development process- joint-development agreements, production agreements, agreements for the purchase of technologies from the academic companies and commercializing institutions, agreements for conducting clinical experiments and agreements for the commercializing of intellectual property in the companies’ product market, and providing continuous legal consulting through the stages of distribution, licensing and production.

Adv. Gazit is a member of the International Bar Association (IBA) (“officer” in official IBA nomenclature), and serves as Co-Chair of the Healthcare and Life Sciences Law Committee of the IBA.

Alongside her professional work, Adv. Gazit lectures before various professional and academic forums, including the International Bar Association, the Coller Ignite Entrepreneurship Club and the Tel Aviv University, where she teaches a course on legal and financial principles for entrepreneurship.


LL.B., Tel Aviv University, 1988

Bar Admission

Israel Bar Association, 1989


The Legal 500 | 2022

"Has renowned proficiency in complex cross-border transactions and strategic investments."

The Legal 500 | 2022

"Life sciences expert who handles cross-border transactions and investments."

The Legal 500 | 2022

"Brings to the table a broad perspective and excellent negotiation skills."

Chambers & Partners | 2021

"Acts for some of the world's most prestigious private equity funds in tenders, financings and acquisitions."

The Legal 500 | 2021

Selected Transactions

Baring Private Equity Asia PTE. Ltd. - Lumenis Ltd.
1.2B USD

Representing Baring Private Equity Asia in its acquisition of Lumenis from the Chinese XIO Group.

TPG Private Equity Fund - Credit Suisse
1.27B USD

Advising TPG regarding a transaction in which it acquired debt assets of Credit Suisse for $1.27 billion (according to media reports).

Becton, Dickinson and Co. - Caesarea Medical Electronics Holding (2000) Ltd.

Representing the controlling shareholders of Caesarea Medical Electronics Holding (2000) Ltd. (CME), in a share acquisition in which Becton, Dickinson and Co. ("BD") acquired 60% of CME's shares.

Nestle - Materna Laboratories Ltd.
269M ILS

Representing Nestle in the acquisition of 51% of Materna Laboratories Ltd. alongside Osem for 269 million ILS.

AGT International GmbH - William Morris Endeavor Entertainment, LLC (WME/IMG)

Representing AGT in a $62 million joint venture agreement with the leading American talent and literary agency WME/IMG.


Advising NEOME, a unique Women's Investment Club which brings together female investors in start-up companies.